MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis

Curtius, K., Wright, N. A. & Graham, T. A. An evolutionary perspective on field cancerization. Nat. Rev. Cancer 18, 19–32 (2018).

Article  CAS  PubMed  Google Scholar 

Dotto, G. P. Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. J. Clin. Invest. 124, 1446–1453 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taniguchi, S. et al. Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression. Science 369, eaay1813 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan, S. et al. Ras drives malignancy through stem cell crosstalk with the microenvironment. Nature 612, 555–563 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell 184, 4734–4752.e20 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, J. H. et al. Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy. Nat. Immunol. 25, 644–658 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong, L.-Q. et al. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma. J. Hepatol. 72, 896–908 (2020).

Article  CAS  PubMed  Google Scholar 

Zucman-Rossi, J., Villanueva, A., Nault, J.-C. & Llovet, J. M. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology 149, 1226–1239.e4 (2015).

Article  CAS  PubMed  Google Scholar 

Mu, X. et al. Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment. J. Clin. Invest. 125, 3891–3903 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Libbrecht, L., Desmet, V. & Roskams, T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int. 25, 16–27 (2005).

Article  CAS  PubMed  Google Scholar 

Lefere, S., Degroote, H., Van Vlierberghe, H. & Devisscher, L. Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers. J. Hepatol. 71, 631–633 (2019).

Article  PubMed  Google Scholar 

Deng, Z. et al. The nuclear factor ID3 endows macrophages with a potent anti-tumour activity. Nature 626, 864–873 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan, D. et al. Kupffer cell-derived Tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS. Cancer Cell 31, 771–789.e6 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu, J. et al. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res. 72, 3977–3986 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blériot, C. et al. A subset of Kupffer cells regulates metabolism through the expression of CD36. Immunity 54, 2101–2116.e6 (2021).

Article  PubMed  Google Scholar 

De Simone, G. et al. Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming. Immunity 54, 2089–2100.e8 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512–518 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salmon, H., Remark, R., Gnjatic, S. & Merad, M. Host tissue determinants of tumour immunity. Nat. Rev. Cancer 19, 215–227 (2019).

CAS  PubMed  PubMed Central  Google Scholar 

Peiseler, M. et al. Kupffer cell-like syncytia replenish resident macrophage function in the fibrotic liver. Science 381, eabq5202 (2023).

Article  CAS  PubMed  Google Scholar 

Goto, N. et al. SOX17 enables immune evasion of early colorectal adenomas and cancers. Nature 627, 636–645 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiang, J. et al. Disruption of SIRT7 increases the efficacy of checkpoint inhibitor via MEF2D regulation of programmed cell death 1 ligand 1 in hepatocellular carcinoma cells. Gastroenterology 158, 664–678.e24 (2020).

Article  CAS  PubMed  Google Scholar 

Ma, L. et al. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2–M transition genes. Cancer Res. 74, 1452–1462 (2014).

Article  CAS  PubMed  Google Scholar 

Xiang, J. et al. A ubiquitin-dependent switch on MEF2D senses pro-metastatic niche signals to facilitate intrahepatic metastasis of liver cancer. Adv. Sci. (Weinh.) 10, e2305550 (2023).

PubMed  Google Scholar 

Gao, T. & Qian, J. EnhancerAtlas 2.0: an updated resource with enhancer annotation in 586 tissue/cell types across nine species. Nucleic Acids Res. 48, D58–D64 (2020).

CAS  PubMed  Google Scholar 

Bakiri, L. et al. Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation. J. Exp. Med. 214, 1387–1409 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Filliol, A. et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature 610, 356–365 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aran, D. et al. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat. Commun. 8, 1077 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Nault, J. C. et al. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat. Commun. 4, 2218 (2013).

Article  PubMed  Google Scholar 

Berardi, D. E. et al. Lipid droplet turnover at the lysosome inhibits growth of hepatocellular carcinoma in a BNIP3-dependent manner. Sci. Adv. 8, eabo2510 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piguet, A.-C. et al. Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis. J. Hepatol. 62, 1296–1303 (2015).

Article  CAS  PubMed  Google Scholar 

Horie, Y. et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest. 113, 1774–1783 (2004).

Article  CAS  PubMed  PubMed Central 

Comments (0)

No login
gif